ATS Medical (ATSI) Posts Q3 Loss of 1c, In-Line with Estimates
More News related to ATSI
- ATS Medical to Participate in the 21st Annual Piper Jaffray Health Care Conference
- ATS Medical to Participate in the 2009 Canaccord Adams Cardiovascular Conference
- Piper Jaffray Upgrades ATS Medical (ATSI) to Overweight; Trims 2010 EPS Outlook
- After-Hours Movers 11/02: BDK, DDRX, ATSI, HLF, HTCH, SNCR, CAR Higher; TNS, HIMX, SVR, TXRH Lower
- ATS Medical (ATSI) Posts Q3 Loss of 1c, In-Line with Estimates
ATS Medical (NASDAQ: ATSI) reports Q3 loss of $0.01, even with the analyst estimate of ($0.01). Revenue for the quarter was $18.80 million, which compares to the estimate of $18.65 million.
Related Categories
EarningsStocks Mentioned
-0.01Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
